Results 121 to 130 of about 6,285 (179)

Fully GMP-complient radiosynthesis of [¹⁶¹Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation. [PDF]

EJNMMI Radiopharm Chem
Kryza D, Le Fur P, Badel JN, Morgat C, Khayi F, Giraudet AL.   +5 more
europepmc   +1 more source

An improved fully-automated GMP radiosynthesis of [¹⁸F]fluoro-pivalic acid with solid-phase extraction purification. [PDF]

EJNMMI Radiopharm Chem
Barnes C, Twyman F, Awais RO, Pritchard D, Glaser M, Turton DR, Brickute D, Smith G, Årstad E, Allott L, Aboagye EO.   +10 more
europepmc   +1 more source

Next-Gen ¹⁸F-Relay Reagent: Optimising [¹⁸F]Ethanesulfonyl Fluoride. [PDF]

Int J Mol Sci
Aulsebrook ML, Pascali G, Tuck KL, Rashid PT, Kubeil M, Hagemeyer CE, Pietzsch J, Laube M.   +7 more
europepmc   +1 more source

Automated clinical production, dosimetry estimates and preclinical safety considerations for clinical translation of a SOAT1-targeted PET imaging agent. [PDF]

Nucl Med Biol
Kaup G, Kaur T, Henderson BD, Winton WP, Hill JR, Raffel DM, Stauff J, Wong KK, Brooks AF, Shao X, Hammer GD, Viglianti BL, Scott PJH.   +12 more
europepmc   +1 more source

Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology.

2-((1E,3E)-4-(6-((11)C-methylamino)pyridin-3-yl)buta-1,3-dienyl)benzo[d]thiazol-6-ol ((11)C-PBB3) is a clinically useful PET probe that we developed for in vivo imaging of tau pathology in the human brain.
Hashimoto, Hiroki, Aihara, Yoshiharu, Nemoto, Kazuyoshi, 469239, 469238, 河村 和紀, 469246, Yamasaki, Tomoteru, 469245, Zhang, Ming-Rong, 469244, 469243, 469242, 469241, 469240, 伊藤 岳人, 羽鳥 晶子, Xie, Lin, 五十嵐 延行, 須原 哲也, 469209, Higuchi, Makoto, Muto, Masatoshi, 469215, 469214, 469213, 469212, 469211, 469210, 武藤 正敏, Fujishiro, Tomoya, 山崎 友照, Furutsuka, Kenji, 藤代 智也, 小野 麻衣子, Shiomi, Satoshi, 469219, 由井 譲二, 469218, 相原 由治, 469217, Hatori, Akiko, Igarashi, Nobuyuki, 469216, 469226, 469225, 469224, 469223, Suhara, Tetsuya, 469222, 古塚 賢士, 469221, 張 明栄, 469220, 武井 誠, Yui, Joji, Ono, Maiko, Kawamura, Kazunori, 樋口 真人, 根本 和義, 469229, 469228, 469227, Takei, Makoto, 469237, 469236, 潮見 聡, 469235, Ito, Takehito, 橋本 裕輝, 469234, 469233, 469232, 469231, 469230, 謝 琳   +75 more
core  

Quantitative μ-Opioid Receptor PET with [¹⁸F]FCFN in Nonhuman Primates: Naloxone Blockade and Within-Scan Displacement. [PDF]

Pharmaceutics
Gallagher E, Downey JW, Yoo CH, Deng H, Fu JF, Qin Q, Bass I, Wey HY, Hooker JM, Sander CY, Lee SJ.   +10 more
europepmc   +1 more source

Automated radiosynthesis of 2-[¹⁸F]BPA for PET-based planning of boron neutron capture therapy (BNCT): rational precursor design, radiofluorination, and characterization of methodology. [PDF]

EJNMMI Radiopharm Chem
Paolillo V, Pham CD, Ta R, Georgiou DK, Manning HC.   +4 more
europepmc   +1 more source

First-In-Human Evaluation of [18F]Fluproxadine for Norepinephrine Transporter PET: Biodistribution, Dosimetry, and Safety. [PDF]

Clin Nucl Med
Yamane T, Iimori H, Akamatsu G, Ikari Y, Hoda Y, Shimizu K, Matsumoto K, Senda M, Werner RA, Nose N, Chen X, Higuchi T.   +11 more
europepmc   +1 more source

Radiosynthesis of three [11C]ureido-substituted benzenesulfonamides as PET probes for carbonic anhydrase IX in tumors

Three ureido-substituted benzenesulfonamides 1a–c have been developed as potent inhibitors for carbonic anhydrase IX, which is overexpressed in hypoxic tumors. In this study, we labeled these unsymmetrical ureas 1a–c using [11C]phosgene ([11C]
福村 利光, Fujinaga, Masayuki, 460067, Asakawa, Chiharu, 460066, 460065, 460064, 由井 譲二, Kumata, Katsushi, 460069, 460068, 460070, 河村 和紀, Yamasaki, Tomoteru, 460052, Zhang, Ming-Rong, 張 明栄, 460071, Yui, Joji, 熊田 勝志, Ogawa, Masanao, Kawamura, Kazunori, Xie, Lin, 460056, 460055, 460054, 460053, 460059, 460058, 浅川 千春, 460057, 460063, 460062, 藤永 雅之, 460061, 460060, 小川 政直, 謝 琳, Fukumura, Toshimitsu, 山崎 友照   +39 more
core  

Nonsteroidal ¹⁸F-Labeled PET Tracer for Imaging Androgen Receptors. [PDF]

J Nucl Med
Jallinoja VIJ, Mun JS, Campanella A, Sasson A, Kalidindi TM, Caxeiro G, Veach DR, Lyashchenko S, Schöder H, Pillarsetty NVK.   +9 more
europepmc   +1 more source